de Cabo, R. & Mattson, M. P. Effects of intermittent fasting on health, aging, and disease. N. Engl. J. Med. 381, 2541â2551 (2019).
Sutton, E. F. et al. Early time-restricted feeding improves insulin sensitivity, blood pressure, and oxidative stress even without weight loss in men with prediabetes. Cell Metab. 27, 1212â1221 e1213 (2018).
Tiwari, S., Sapkota, N. & Han, Z. Effect of fasting on cancer: a narrative review of scientific evidence. Cancer Sci. 113, 3291â3302 (2022).
Harris, L. et al. Intermittent fasting interventions for treatment of overweight and obesity in adults: a systematic review and meta-analysis. JBI Database System. Rev. Implement. Rep. 16, 507â547 (2018).
Tan-Shalaby, J. Ketogenic diets and cancer: emerging evidence. Fed. Pract. 34, 37Sâ42S (2017).
Dowis, K. & Banga, S. The potential health benefits of the ketogenic diet: a narrative review. Nutrients 13, 1654 (2021).
Yuan, C. L. et al. Preserved protein synthesis in the heart in response to acute fasting and chronic food restriction despite reductions in liver and skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 295, E216âE222 (2008).
Afolabi, P. R. et al. The effect of total starvation and very low energy diet in lean men on kinetics of whole body protein and five hepatic secretory proteins. Am. J. Physiol. Endocrinol. Metab. 293, E1580âE1589 (2007).
Zahra, A. et al. Consuming a ketogenic diet while receiving radiation and chemotherapy for locally advanced lung cancer and pancreatic cancer: the University of Iowa experience of two phase 1 clinical trials. Radiat. Res. 187, 743â754 (2017).
Hopkins, B. D. et al. Suppression of insulin feedback enhances the efficacy of PI3K inhibitors. Nature 560, 499â503 (2018).
Puchalska, P. & Crawford, P. A. Metabolic and signaling roles of ketone bodies in health and disease. Annu. Rev. Nutr. 41, 49â77 (2021).
Sengupta, S., Peterson, T. R., Laplante, M., Oh, S. & Sabatini, D. M. mTORC1 controls fasting-induced ketogenesis and its modulation by ageing. Nature 468, 1100â1104 (2010).
Dowling, R. J. et al. mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs. Science 328, 1172â1176 (2010).
Waskiewicz, A. J., Flynn, A., Proud, C. G. & Cooper, J. A. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J. 16, 1909â1920 (1997).
Furic, L. et al. eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression. Proc. Natl Acad. Sci. USA 107, 14134â14139 (2010).
Wendel, H. G. et al. Dissecting eIF4E action in tumorigenesis. Genes Dev. 21, 3232â3237 (2007).
Scheper, G. C. & Proud, C. G. Does phosphorylation of the cap-binding protein eIF4E play a role in translation initiation? Eur. J. Biochem. 269, 5350â5359 (2002).
Zhulyn, O. et al. Evolutionarily divergent mTOR remodels translatome for tissue regeneration. Nature 620, 163â171 (2023).
Morita, M. et al. mTOR coordinates protein synthesis, mitochondrial activity and proliferation. Cell Cycle 14, 473â480 (2015).
Guillon, J. et al. tRNA biogenesis and specific aminoacyl-tRNA synthetases regulate senescence stability under the control of mTOR. PLoS Genet. 17, e1009953 (2021).
Casals, N. et al. Regulation of the expression of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene. Its role in the control of ketogenesis. Biochem. J. 283, 261â264 (1992).
Kersten, S. et al. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J. Clin. Invest. 103, 1489â1498 (1999).
Montagner, A. et al. Liver PPARalpha is crucial for whole-body fatty acid homeostasis and is protective against NAFLD. Gut 65, 1202â1214 (2016).
Xu, Y. et al. Translation control of the immune checkpoint in cancer and its therapeutic targeting. Nat. Med. 25, 301â311 (2019).
Reich, S. H. et al. Structure-based design of pyridone-aminal eFT508 targeting dysregulated translation by selective mitogen-activated protein kinase interacting kinases 1 and 2 (MNK1/2) inhibition. J. Med. Chem. 61, 3516â3540 (2018).
Venable, A. H. et al. Fasting-induced HMGCS2 expression in the kidney does not contribute to circulating ketones. Am. J. Physiol. Renal Physiol. 322, F460âF467 (2022).
Truitt, M. L. et al. Differential requirements for eIF4E dose in normal development and cancer. Cell 162, 59â71 (2015).
Hsieh, A. C. et al. The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature 485, 55â61 (2012).
Wu, J. C., Merlino, G. & Fausto, N. Establishment and characterization of differentiated, nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor alpha. Proc. Natl Acad. Sci. USA 91, 674â678 (1994).
Grygiel-Gorniak, B. Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implicationsâa review. Nutr. J. 13, 17 (2014).
DiMarco, N. M., Beitz, D. C. & Whitehurst, G. B. Effect of fasting on free fatty acid, glycerol and cholesterol concentrations in blood plasma and lipoprotein lipase activity in adipose tissue of cattle. J. Anim. Sci. 52, 75â82 (1981).
Abe, I. et al. Lipolysis-derived linoleic acid drives beige fat progenitor cell proliferation. Dev. Cell 57, 2623â2637 e2628 (2022).
Fukunaga, R. & Hunter, T. MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. EMBO J. 16, 1921â1933 (1997).
Li, Y. et al. Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and eIF4E. Neoplasia 12, 848â855 (2010).
Bujak, A. L. et al. AMPK activation of muscle autophagy prevents fasting-induced hypoglycemia and myopathy during aging. Cell Metab. 21, 883â890 (2015).
Minokoshi, Y. et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428, 569â574 (2004).
Shveygert, M., Kaiser, C., Bradrick, S. S. & Gromeier, M. Regulation of eukaryotic initiation factor 4E (eIF4E) phosphorylation by mitogen-activated protein kinase occurs through modulation of Mnk1-eIF4G interaction. Mol. Cell. Biol. 30, 5160â5167 (2010).
Parra, J. L., Buxade, M. & Proud, C. G. Features of the catalytic domains and C termini of the MAPK signal-integrating kinases Mnk1 and Mnk2 determine their differing activities and regulatory properties. J. Biol. Chem. 280, 37623â37633 (2005).
Goto, S., Yao, Z. & Proud, C. G. The C-terminal domain of Mnk1a plays a dual role in tightly regulating its activity. Biochem. J 423, 279â290 (2009).
Xiao, B. et al. Structural basis for AMP binding to mammalian AMP-activated protein kinase. Nature 449, 496â500 (2007).
Oakhill, J. S. et al. AMPK is a direct adenylate charge-regulated protein kinase. Science 332, 1433â1435 (2011).
Pinkosky, S. L. et al. Long-chain fatty acyl-CoA esters regulate metabolism via allosteric control of AMPK beta1 isoforms. Nat. Metab. 2, 873â881 (2020).
Li, X. et al. Erratum: structural basis of AMPK regulation by adenine nucleotides and glycogen. Cell Res. 25, 398 (2015).
Chen, L. et al. Conserved regulatory elements in AMPK. Nature 498, E8âE10 (2013).
Xin, F. J., Wang, J., Zhao, R. Q., Wang, Z. X. & Wu, J. W. Coordinated regulation of AMPK activity by multiple elements in the alpha-subunit. Cell Res. 23, 1237â1240 (2013).
Steinberg, G. R. & Hardie, D. G. New insights into activation and function of the AMPK. Nat. Rev. Mol. Cell Biol. 24, 255â272 (2023).
Gouirand, V. et al. Ketogenic HMG-CoA lyase and its product beta-hydroxybutyrate promote pancreatic cancer progression. EMBO J. 41, e110466 (2022).
Gwinn, D. M. et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 30, 214â226 (2008).
Hoppe, S. et al. AMP-activated protein kinase adapts rRNA synthesis to cellular energy supply. Proc. Natl Acad. Sci. USA 106, 17781â17786 (2009).
Basu, S. S. & Blair, I. A. SILEC: a protocol for generating and using isotopically labeled coenzyme A mass spectrometry standards. Nat. Protoc. 7, 1â12 (2011).
Liu, X. et al. High-resolution metabolomics with acyl-CoA profiling reveals widespread remodeling in response to diet. Mol. Cell Proteomics 14, 1489â1500 (2015).
MacLean, B. et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26, 966â968 (2010).
Kawaguchi, A., Yoshimura, T. & Okuda, S. A new method for the preparation of acyl-CoA thioesters. J. Biochem. 89, 337â339 (1981).
Jo, S., Kim, T., Iyer, V. G. & Im, W. CHARMM-GUI: a web-based graphical user interface for CHARMM. J. Comput. Chem. 29, 1859â1865 (2008).
Lundborg, M. & Lindahl, E. Automatic GROMACS topology generation and comparisons of force fields for solvation free energy calculations. J. Phys. Chem. B 119, 810â823 (2015).
Gu, X. et al. Deconvoluting AMP-activated protein kinase (AMPK) adenine nucleotide binding and sensing. J. Biol. Chem. 292, 12653â12666 (2017).
Yan, Y. et al. Structure of an AMPK complex in an inactive, ATP-bound state. Science 373, 413â419 (2021).
Feenstra, K. A., Hess, B. & Berendsen, H. J. C. Improving efficiency of large time-scale molecular dynamics simulations of hydrogen-rich systems. J. Comput. Chem. 20, 786â798 (1999).
Gao, Y. et al. CHARMM-GUI supports hydrogen mass repartitioning and different protonation states of phosphates in lipopolysaccharides. J. Chem. Inf. Model. 61, 831â839 (2021).
